Table 3.
Vertebral body level and MLC type used for the 22 NRG Oncology RTOG 0631 cases used in this study. The * indicates submitted cases that were non-protocol compliant due to dose in the NonPTV1600 structure.
| Patient # | Level | MLC Type |
|---|---|---|
| A | T9 | HD/HD |
| B | T7 | M/M |
| C | L2 | ?/M |
| D* | L4 | HD/HD |
| E | L2-L3 | HD/HD |
| F | L4-L5 | ?/M |
| G | L5 | M/M |
| H | L1 | HD/HD |
| I | L2 | M/M |
| J | T8 | HD/HD |
| K* | T2-T3 | HD/HD |
| L | C3-C4 | HD/HD |
| M | C3-C4 | HD/HD |
| N | T8-T9 | ?/M |
| O | T1-T2 | ?/M |
| P | L3-L4 | ?/M |
| Q | T10-T11 | ?/M |
| R | T2-T3 | HD/HD |
| S | L3-L4 | HD/HD |
| T | T6 | ?/M |
| U | L1-L2 | ?/M |
| V | T9 | ?/M |
MLC = multileaf collimator, M = millennium MLC, HD = high-definition MLC, OAR = organ at risk, PTV = planning target volume